Sun confident over Ranbaxy deal competition scrutiny
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries is hopeful that a "satisfactory solution" will emerge from the ongoing scrutiny of its acquisition of Ranbaxy Laboratories by India's competition regulator.